Gagnon Advisors, LLC Profound Medical Corp. Transaction History

Gagnon Advisors, LLC

$125 Million
Q1 2025

A detailed history of Gagnon Advisors, LLC transactions in Profound Medical Corp. stock. As of the latest transaction made, Gagnon Advisors, LLC holds 896,671 shares of PROF stock, worth $5.11 Million. This represents 4.19% of its overall portfolio holdings.

Number of Shares

896,671

Previous 896,671 -0.0%

Holding current value

$5.11 Million

Previous $6.73 Million 22.5%

% of portfolio

4.19%

Previous 4.87%

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Jan 23, 2025	BUY	$6.98 - $8.96 $1.04 Million - $1.34 Million	149,445 Added 20.0%	896,671 $6.73 Million
Q1 2024 May 13, 2024	BUY	$7.3 - $9.46 $495,889 - $642,617	67,930 Added 10.0%	747,226 $6.37 Million
Q2 2023 Aug 08, 2023	BUY	$9.27 - $14.88 $285,803 - $458,765	30,831 Added 4.75%	679,296 $8.84 Million
Q3 2022 Nov 14, 2022	BUY	$3.99 - $9.3 $827,561 - $1.93 Million	207,409 Added 47.03%	648,465 $2.62 Million
Q1 2022 May 09, 2022	BUY	$8.16 - $11.33 $317,252 - $440,499	38,879 Added 9.67%	441,056 $3.97 Million
Q3 2021 Nov 12, 2021	BUY	$13.6 - $17.88 $1.7 Million - $2.23 Million	124,925 Added 45.06%	402,177 $5.89 Million
Q3 2020 Nov 12, 2020	BUY	$14.05 - $18.13 $287,167 - $370,559	20,439 Added 7.96%	277,252 $4.89 Million
Q2 2020 Aug 14, 2020	BUY	$9.41 - $16.94 $592,387 - $1.07 Million	62,953 Added 32.47%	256,813 $4.35 Million
Q2 2020 Aug 13, 2020	SELL	$9.41 - $16.94 $592,387 - $1.07 Million	-62,953 Reduced 24.51%	193,860 $4.35 Million
Q1 2020 May 11, 2020	BUY	$6.88 - $19.7 $1.77 Million - $5.06 Million	256,813 New	256,813 $2.5 Million

Others Institutions Holding PROF

# of Institutions

Shares Held

13M

Call Options Held

3.3K

Put Options Held

9.3K

View Full List

About Profound Medical Corp.

Ticker PROF
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 20,851,300
Market Cap $119M
Description
Profound Medical Corp., together with its subsidiaries, operates as a commercial-stage medical device company that develops magnetic resonance guided ablation procedures for treatment of prostate disease, uterine fibroids, and palliative pain treatment in Canada, Germany, the United States, and Finland. Its lead product TULSA-PRO system used for...

More about PROF

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Gagnon Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Gagnon Advisors, LLC with notifications on news.

Account

Gagnon Advisors, LLC Profound Medical Corp. Transaction History